After the benchmark S&P/ASX 200 surged 7.5 per cent in 2024, investors are looking to see where the growth will come from in ...

Cell therapies have suffered from hyped-up expectations, clinical setbacks and high costs. But maybe, just maybe, Arovella is ...

ASX climbs while Bitcoin surges past US$102k thanks to Trump’s crypto push and Capricorn hits a gold output record.

Riversgold’s (ASX:RGL) rock chip sampling is defining multiple multi-metal targets across the ~25 km strike of the Saint John ...

The advent of a Trump presidency is accelerating a divergence on digital currencies between the world’s two largest economies ...

ASX tech rocked a 50pc gain in 2024, Archer Materials shone in December, and Dubber and Brainchip have cashed in on major ...

Special Report: James Bay Minerals is progressing exploration at its Independence gold project in Lander County, Nevada, with ...

Kalamazoo Resources led materials sector gainers this morning as the release of drill assays from its Mallina West gold ...

Opyl has entered a joint venture with X Firm to market its TrialKey platform in key markets, while Dimerix has inked another ...

Neurizon recently received EMA orphan designation for NUZ-001 to treat ALS and filed an FDA IND application to begin a phase ...

Fraser Palamara details Dimerix's (ASX:DXB) deal with Japanese pharmaceutical company FUSO to fight a deadly kidney disease.

Summit Minerals led resource gainers after signing a deal to acquire the Mundo Novo niobium and rare earths project in central Brazil.